Insider Trading Activity Amedisys Inc (NASDAQ:AMED) – Director Bought 2,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For Amedisys Inc (NASDAQ:AMED)

Bruce D Perkins , Director of Amedisys Inc (NASDAQ:AMED) reportedly Bought 2,000 shares of the company’s stock at an average price of 46.6 for a total transaction amount of $93,200.00 SEC Form

Insider Trading History For Amedisys Inc (NASDAQ:AMED)

  • On 7/3/2013 Linda J Hall, Director, sold 1,721 with an average share price of $10.65 per share and the total transaction amounting to $18,328.65.View SEC Filing
  • On 10/18/2013 Kkr Asset Management Llc, Major Shareholder, bought 12,652 with an average share price of $17.95 per share and the total transaction amounting to $227,103.40.View SEC Filing
  • On 10/22/2013 Kkr Asset Management Llc, Major Shareholder, bought 186,013 with an average share price of $17.55 per share and the total transaction amounting to $3,264,528.15.View SEC Filing
  • On 10/30/2013 Kkr Asset Management Llc, Major Shareholder, bought 29,615 with an average share price of $15.94 per share and the total transaction amounting to $472,063.10.View SEC Filing
  • On 11/14/2013 Kkr Asset Management Llc, major shareholder, bought 946,500 with an average share price of $13.89 per share and the total transaction amounting to $13,146,885.00.View SEC Filing
  • On 11/15/2013 David Bucey, General Counsel, sold 8,290 with an average share price of $13.95 per share and the total transaction amounting to $115,645.50.View SEC Filing
  • On 11/21/2013 Kkr Asset Management Llc, major shareholder, bought 425,515 with an average share price of $14.48 per share and the total transaction amounting to $6,161,457.20.View SEC Filing

    • Analyst Ratings For Amedisys Inc (NASDAQ:AMED)
    These are 4 Hold Ratings, 4 Buy Ratings .
    The current consensus rating for Amedisys Inc (NASDAQ:AMED) is Buy (Score: 2.50) with a consensus target price of $56.14 , a potential (19.33% upside)

    Analyst Ratings History For Amedisys Inc (NASDAQ:AMED)

    • On 11/6/2015 Piper Jaffray Companies Reiterated Rating Neutral with a price target of $42.00 to $45.00
    • On 1/11/2016 Raymond James Financial, Inc. Upgraded rating Underperform to Market Perform
    • On 5/16/2016 Robert W. Baird Reiterated Rating Hold
    • On 9/11/2016 Wells Fargo & Company Reiterated Rating Buy
    • On 1/17/2017 Craig Hallum Set Price Target of rating Buy with a price target of $60.00
    • On 3/3/2017 Oppenheimer Holdings, Inc. Reiterated Rating Outperform with a price target of $50.00 to $59.00
    • On 4/28/2017 Jefferies Group LLC Reiterated Rating Buy with a price target of $57.00

    Recent Trading Activity for Amedisys Inc (NASDAQ:AMED)
    Shares of Amedisys Inc closed the previous trading session at 47.05 down -0.22 -0.47% with 452,364 shares trading hands.